Invenomic Capital Management’s AdvanSix ASIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Sell
128,043
-185,506
-59% -$4.18M 0.15% 98
2026
Q1
$7.65M Sell
313,549
-12,678
-4% -$239K 0.35% 78
2025
Q4
$5.64M Buy
326,227
+13,856
+4% +$242K 0.26% 104
2025
Q3
$6.05M Buy
+312,371
New +$6.57M 0.29% 96

Other funds holding ASIX

Invenomic Capital Management's ASIX Position: Q2 2026 in Review

Invenomic Capital Management reduced its AdvanSix (ASIX) stake by 59% in Q2 2026, selling an estimated $4.18M and leaving 128,043 shares worth $2.55M. The position accounts for 0.15% of the portfolio, ranked #98.

Invenomic Capital Management first reported a position in ASIX in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.65M in Q1 2026. 254 funds tracked by Wall St. Rank hold ASIX as of Q2 2026.

  • Invenomic Capital Management held 128,043 shares of AdvanSix worth $2.55M as of Q2 2026.
  • Invenomic Capital Management sold 185,506 AdvanSix shares in Q2 2026, an estimated $4.18M.
  • AdvanSix made up 0.15% of Invenomic Capital Management's portfolio in Q2 2026, its #98 holding.
  • Invenomic Capital Management first reported a position in AdvanSix in Q3 2025 and has held it in 4 quarters since.
  • Invenomic Capital Management's AdvanSix position peaked at $7.65M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held AdvanSix as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.